PIASγ Enhanced SUMO-2 Modification of Nurr1 Activation-Function-1 Domain Limits Nurr1 Transcriptional Synergy

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Arredondo, Cristian ^a   Orellana, Marcelo ^a   Vecchiola, Andrea ^a   Pereira, Luis Alberto ^a   Galdames, Leopoldo ^a   Andrés, María Estela ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

LIGASE; LYSINE; NUCLEAR RECEPTOR RELATED FACTOR 1; PIAS GAMMA PROTEIN; SUMO 2 PROTEIN; SUMO LIGASE; SUMO PROTEIN; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; IN VITRO STUDY; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; SUMOYLATION; TRANSACTIVATION; TRANSCRIPTION INITIATION; UPREGULATION; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL LINE; HUMANS; IMMUNOPRECIPITATION; MICROSCOPY, CONFOCAL; NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 2; PROTEIN INHIBITORS OF ACTIVATED STAT; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; TRANSCRIPTION, GENETIC;

EID: 84872843475     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055035     Document Type: Article

References (35)

1. Perlmann T, Wallén-Mackenzie A, (2004) Nurr1, an orphan nuclear receptor with essential functions in developing dopamine cells. Cell Tissue Res 318: 45-52.
2. Maxwell MA, Muscat GE, (2006) The NR4A subgroup: immediate early response genes with pleiotropic physiological roles. Nucl Recept Signal 4: e002.
3. Maruyama K, Tsukada T, Ohkura N, Bandoh S, Hosono T, et al. (1998) The NGFI-B subfamily of the nuclear receptor superfamily. Int J Oncol 12: 1237-1243.
4. Wang Z, Benoit G, Liu J, Prasad S, Aarnisalo P, et al. (2003) Structure and function of Nurr1 identifies a class of ligand-independent nuclear receptors. Nature 423: 555-560.
5. Castro DS, Arvidsson M, Bondesson-Bolin M, Perlmann T, (1999) Activity of the Nurr1 carboxy-terminal domain depends on cell type and integrity of the activation function 2. J Biol Chem 274: 37483-37490.
6. Palvimo JJ, (2007) PIAS proteins as regulators of small ubiquitin-related modifier (SUMO) modifications and transcription. Biochem Soc Trans 35: 1405-1048.
7. Schmidt D, Müller S, (2003) PIAS/SUMO: new partners in transcriptional regulation. Cell Mol Life Sci 60: 2561-2574.
8. Galleguillos D, Vecchiola A, Fuentealba JA, Ojeda V, Alvarez K, et al. (2004) PIASgamma represses the transcriptional activation induced by the nuclear receptor Nurr1. J Biol Chem 279: 2005-2011.
9. Geiss-Friedlander R, Melchior F, (2007) Concepts in sumoylation: a decade on. Nat Rev Mol Cell Biol 8: 947-956.
10. Yeh ET, (2009) SUMOylation and De-SUMOylation: wrestling with life's processes. J Biol Chem 284: 8223-8227.
11. Johnson ES, (2004) Protein modification by SUMO. Annu Rev Biochem 73: 355-382.
12. Hay RT, (2005) SUMO: a history of modification. Mol Cell 18: 1-12.
13. Poukka H, Karvonen U, Janne OA, Palvimo JJ, (2000) Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1). Proc Natl Acad Sci USA 97: 14145-14150.
14. Iñiguez-Lluhí JA, Pearce D, (2000) A common motif within the negative regulatory regions of multiple factors inhibits their transcripcional synergy. Mol Cell Biol 20: 6040-6050.
15. Woronicz JD, Lina A, Calnan BJ, Szychowski S, Cheng L, et al. (1995) Regulation of the Nur77 orphan steroid receptor in activation-induced apoptosis. Mol Cell Biol 15: 6364-6376.
16. Bailey D, O'Hare P, (2004) Characterization of the localization and proteolytic activity of the SUMO-specific protease, SENP1. J Biol Chem 279: 692-703.
17. Gómez AV, Galleguillos D, Maass JC, Battaglioli E, Kukuljan M, et al. (2008) CoREST represses the heat shock response mediated by HSF1. Mol Cell 31: 222-231.
18. Blanco EH, Zúñiga JP, Andrés ME, Alvarez AR, Gysling K, (2011) Corticotropin-releasing factor binding protein enters the regulated secretor pathway in neuroendocrine cells and cortical neurons. Neuropeptides 45: 273-279.
19. van Steensel B, van Binnendijk EP, Hornsby CD, van der Voort HT, Krozowski ZS, et al. (1996) Partial colocalization of glucocorticoid and mineralocorticoid receptors in discrete compartments in nuclei of rat hippocampus neurons. J Cell Sci. 109: 787-792.
20. Nishida T, Terashima M, Fukami K, (2006) PIASγ-mediated repression of the Ets-1 is independent of its sumoylation. Biochem Biophys Res Commun 345: 1536-1546.
21. Savkur RS, Burris TP, (2004) The coactivator LXXLL nuclear receptor recognition motif. J Pept Res. 63: 207-212.
22. Jo AY, Kim MY, Lee HS, Rhee YH, Lee JE, et al. (2009) Generation of dopamine neurons with improved cell survival and phenotype maintenance using a degradation-resistant nurr1 mutant. Stem Cells 27: 2238-2246.
23. Mukherjee S, Cruz-Rodríguez O, Bolton E, Iñiguez-Lluhí JA, (2012) The in vivo role of Androgen Receptor SUMOylation as revealed by androgen insensitivity syndrome and prostate cancer mutations targeting the proline/glycine residues of synergy control motifs. J Biol Chem 287: 31195-31206.
24. Gareau JR, Lima CD, (2010) The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition. Nat Rev Mol Cell Biol 11: 861-871.
25. Saijo K, Winner B, Carson CT, Collier JG, Boyer L, et al. (2009) A Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death. Cell 137: 47-59.
26. Abdel-Hafiz H, Dudevoir ML, Horwitz KB, (2009) Mechanisms underlying the control of progesterone receptor transcriptional activity by SUMOylation. J Biol Chem 284: 9099-9108.
27. Belaguli NS, Zhang M, García AH, Berger DH, (2012) PIAS1 is a GATA4 SUMO ligase that regulates GATA4-dependent intestinal promoters independent of SUMO ligase activity and GATA4 sumoylation. PLoS One 7: e35717.
28. Georges A, Benayoun BA, Marongiu M, Dipietromaria A, L'Hôte D, et al. (2011) SUMOYlation of the Forkhead transcription factor FOXL2 promotes its stabilization/activation through transient recruitment to PML bodies. PLoS One 6: e25463.
29. Holmstrom S, Van Antwerp ME, Iñiguez-Lluhi JA, (2003) Direct and distinguishable inhibitory roles for SUMO isoforms in the control of transcriptional synergy. Proc Natl Acad Sci USA 100: 15758-15763.
30. Abdel-Hafiz HA, Horwitz KB, (2012) Control of progesterone receptor transcriptional synergy by SUMOylation and deSUMOylation. BMC Mol Biol 13: 10.
31. Holmstrom SR, Chupreta S, So AY, Iñiguez-Lluhí JA, (2008) SUMO-mediated inhibition of glucocorticoid receptor synergistic activity depends on stable assembly at the promoter but not on DAXX. Mol. Endocrinol 22: 2061-2075.
32. Tremblay AM, Wilson BJ, Yang XJ, Giguère V, (2008) Phosphorylation-dependent sumoylation regulates estrogen-related receptor-alpha and -gamma transcriptional activity through a synergy control motif. Mol Endocrinol 22: 570-584.
33. Kim KS, Kim CH, Hwang DY, Seo H, Chung S, et al. (2003) Orphan nuclear receptor Nurr1 directly transactivates the promoter activity of the tyrosine hydroxylase gene in a cell-specific manner. J Neurochem 85: 622-634.
34. Galleguillos D, Fuentealba JA, Gómez LM, Saver M, Gómez A, et al. (2010) Nurr1 regulates RET expresión in dopamine neurons of adult midbrain. J Neurochem 114: 1158-1167.
35. Sacchetti P, Brownschidle LA, Granneman JG, Bannon MJ, (1999) Characterization of the 5′-flanking region of the human dopamine transporter gene. Brain Res Mol Brain Res 74: 167-174.